Verified source brief

STAT+: Roche to buy PathAI for $750 million

Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.

Illustrated brief card for a source-linked news item

Source Wire Desk Briefs Source-linked brief

Source brief

Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.

Original source

This is a source-linked brief from STAT. Read the original item at STAT+: Roche to buy PathAI for $750 million.

Attribution

VINI publishes the headline, source metadata, short feed summary, topic labels, and outbound source link for reader discovery. The full article remains with the original publisher.

Published by source: 2026-05-08T19:29:36+00:00

This source-linked brief summarizes publisher-provided metadata and links to the original report. VINI does not republish third-party article bodies without rights clearance. 1 source listed.

Source links

STAT+: Roche to buy PathAI for $750 millionSTAT - 2026-05-08T19:29:36+00:00

Reader comments

Moderated discussion

Account access

Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.

Loading comments.